DNA RNA and Cells

10 May 2011 Gentium Announces Submission of a Marketing Authorization Application for Defibrotide to the European Medicines Agency
10 May 2011 Nation’s Second Participant Enrolls in Human Embryonic Stem Cell Trial
04 May 2011 Molecular Templates Announces RNAi Drug-Delivery Research Collaboration with Alnylam Pharmaceuticals
04 May 2011 AVI BioPharma Initiates Clinical Studies for Two RNA-Based Therapeutic Candidates for Treatment of Ebola and Marburg Viruses
04 May 2011 Santaris Pharma A/S Advances New Cholesterol-Lowering Drug, SPC5001 Inhibiting Exciting New Target PCSK9, Into Phase 1 Clinical Trials for the Treatment of High Cholesterol
28 Apr 2011 ACT Announces UCLA Institutional Review Board (IRB) Approval of its Phase 1/2 Clinical Trials using hESC-Derived RPE Cells for the Treatment of Macular Degeneration
28 Apr 2011 RXi Pharmaceuticals and the University of Massachusetts Medical School Announce Massachusetts Life Sciences Center Cooperative Research Grant for RNAi Therapeutics for ALS
26 Apr 2011 International Stem Cell Successfully Completes First Series of Preclinical Testing of Hepatocytes Derived from Human Parthenogenetic Stem Cells
22 Apr 2011 Idera Pharmaceuticals Delays Initiation of Phase 2 Clinical Trial of IMO-2125 in Treatment-Naïve HCV Patients
22 Apr 2011 Genta Updates Guidance on Survival Results from Phase 3 AGENDA Trial of Genasense in Advanced Melanoma
21 Apr 2011 Stanford and SanBio Announce a Clinical Trial of Cell Therapy for Stroke Disability
21 Apr 2011 Jennerex and Green Cross Announce Publication of Positive Clinical Data of JX-594 in Combination With Sorafenib in Advanced Liver Cancer
20 Apr 2011 Harvest Technologies Announces Initial Enrollment in Its REVIVE-1 Trial (REtrograde Vascular Infusion of BMAC to ImproVe Heart FailurE)
20 Apr 2011 Marina Biotech Completes Enrollment of Its First Cohort in the START-FAP Clinical Trial of CEQ508
20 Apr 2011 Oncolytics Biotech Inc. Announces Positive Data from Translational Clinical Trial Investigating REOLYSIN in Patients with Metastatic Colorectal Cancer
20 Apr 2011 ACT Files European Clinical Trial Application for Phase 1/2 Study Using Embryonic Stem Cells to Treat Macular Degeneration
20 Apr 2011 Dynavax Initiates First Human Trial in Lupus Program
19 Apr 2011 Tissue Genesis Begins FDA-Approved Clinical Trial
18 Apr 2011 StemCells, Inc. Advances Alzheimer's Disease Program Through Collaboration With Leading Researcher
14 Apr 2011 Regulus Therapeutics and UC San Diego to Collaborate on Angiogenic Disease Research Utilizing microRNA Technology
13 Apr 2011 Cellular Dynamics Licenses Technology From ViaCyte
13 Apr 2011 Pluristem Announces Encouraging Six-Month Follow-Up Results of Its Phase I Critical Limb Ischemia Clinical Trials
13 Apr 2011 Plasticell Spins Out Regenerative Drug Discovery Venture Called 'Progenitor Labs'
11 Apr 2011 AVI BioPharma Receives Approval of Nonproprietary Name Eteplirsen for Lead Duchenne Muscular Dystrophy Therapeutic Candidate, AVI-4658
08 Apr 2011 StemCells, Inc. Discontinues Batten Disease Program

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up